Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayJul 09, 2025 9:00 am

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers

NetworkNewsWire Editorial Coverage: Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease worldwide, a toll that is projected to rise in the coming decades. By 2050, the American Cancer Society estimates that annual cancer diagnoses will reach 35 million. While advances in treatment have improved outcomes for some patients, the demand for more effective therapies remains urgent — and the opportunity for innovation and market impact is significant. Calidi Biotherapeutics Inc. (NYSE American: CLDI) (Profile) is taking a bold approach to this challenge with a next-generation platform designed to…

Continue Reading

TuesdayJul 08, 2025 9:45 am

Safe Pro Group Inc. (NASDAQ: SPAI) Joins Russell Microcap(R) Index, Signaling Growing Investor Recognition, Market Visibility

Safe Pro leverages patented AI and drone-based imagery analysis for threat detection and demining efforts. Membership in the index reflects the company’s growing market presence and performance in AI-powered security and defense solutions, boosting visibility among institutional investors and fund managers. The company’s flagship SpotlightAI(TM) platform has analyzed over 1.6 million real-world battlefield images from Ukraine, identifying more than 28,000 explosive threats. Safe Pro is targeting a share of the global $15 billion defense technology market through its U.S.-made and HUBZone-certified offerings. Safe Pro Group (NASDAQ: SPAI), an emerging provider of AI-powered security and threat detection solutions, announced its addition…

Continue Reading

TuesdayJul 08, 2025 9:00 am

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic

The acquisition of Cohen and Associates, a respected interventional psychiatry practice, by NRx subsidiary HOPE Therapeutics, is expected to be immediately accretive to revenue and EBITDA. Cohen, serving the Sarasota-Bradenton area in Florida, specializes in treatments, including ketamine and TMS, for mood disorders, PTSD, and suicidal depression. HOPE Therapeutics is expanding toward a target of 30 clinics with a $100 million run rate by the end of 2025. NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its wholly-owned subsidiary HOPE Therapeutics, Inc., a multi-site clinical care delivery organization, recently signed a binding letter of intent to acquire a 49%…

Continue Reading

MondayJul 07, 2025 12:30 pm

New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Positioned to Supply Critical Global Silver Demand from Bolivia Assets

New Pacific Metals owns two of the largest undeveloped open-pit silver projects globally, both located in Bolivia. Its flagship Silver Sand project is projected to produce 12 million ounces of silver annually at low all-in sustaining costs. The Carangas project could add 6.6 million ounces of silver annually, with over 1 million ounces of gold potential at depth. New Pacific is working through Bolivia’s permitting process to unlock the upside potential of its high-quality, large-scale projects. Global silver demand, particularly for industrial and renewable energy applications, adds urgency to project development. New Pacific Metals (NYSE American: NEWP) (TSX: NUAG), a…

Continue Reading

MondayJul 07, 2025 11:50 am

Clene Inc. (NASDAQ: CLNN) to Conduct Neurofilament Biomarker Analysis for CNM-Au8(R) in ALS in Early Q4 2025

The FDA offered supportive feedback on Clene’s proposed statistical analysis plan during a recent Type C meeting. The neurofilament biomarker analysis results could support an accelerated approval submission for CNM-Au8 later in 2025. Clene has two additional FDA meetings scheduled in Q3 2025 to discuss ALS survival data and its MS program. Nearly 200 ALS patients are participating in the NIH-sponsored Expanded Access Program for CNM-Au8. The analysis aims to validate the neuroprotective effects shown in previous HEALEY Platform Trial results. Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving…

Continue Reading

MondayJul 07, 2025 11:05 am

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Drives Metallurgical Testing to Unlock Santa Fe Value

Lahontan has commenced column leach testing at Santa Fe, targeting more efficient cyanide leach gold recovery in the mixed oxide-sulfide transition zone The Santa Fe project serves as the backbone of Lahontan's development strategy Beyond metallurgical testing, Lahontan is preparing for an expanded 2025 drilling campaign to resource growth and project optimization Lahontan (TSX.V: LG) (OTCQB: LGCXF) is accelerating its mission to develop top-tier gold and silver assets in Nevada’s renowned Walker Lane, with a renewed focus on advancing the Santa Fe project toward production. In its latest strategic move to accomplish that mission, the company has initiated in-depth metallurgical…

Continue Reading

MondayJul 07, 2025 9:00 am

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs

NetworkNewsWire Editorial Coverage: An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people a year worldwide with these numbers expected to grow. The American Cancer Society projects that by 2050, 35 million people will be diagnosed with cancer every year. Despite significant progress made in treating the disease, there is still a desperate need — and an enormous market potential — for new and more effective cancer drugs. Calidi Biotherapeutics Inc. (NYSE American: CLDI) (Profile) is committed to developing a novel approach to treating cancer through the precise delivery of genetic medicines to both…

Continue Reading

ThursdayJul 03, 2025 12:00 pm

BlueSky AI Inc. (BSAI) Expands Market Presence with Strategic Milestones in AI Infrastructure

BlueSky AI has positioned itself at the forefront of the booming AI infrastructure market through the introduction of its flagship SkyMod modular data centers BSAI’s vision is to empower the AI ecosystem, enabling companies to focus on innovation while they provide the critical infrastructure needed to succeed By focusing on universal computing needs rather than tying itself to single AI applications, BlueSky offers an investment proposition rooted in scale and resilience BlueSky AI (OTC: BSAI) has rapidly emerged as a key player in modular AI data center infrastructure, achieving major milestones in the past two years. The company has moved from…

Continue Reading

ThursdayJul 03, 2025 11:15 am

Nutriband Inc. (NASDAQ: NTRB) Added to Four Key Indexes, Rethinking Opioid Safety in a Time of Crisis

Nutriband and Kindeva have completed commercial-scale manufacturing for AVERSA(TM) Fentanyl, a major milestone in the path to FDA approval Updated analyst report raises NTRB’s price target to $15.00 and reiterates an Outperform rating, citing favorable trial pathway and strong execution Aversa abuse-deterrent tech is protected by international patents and may address a global unmet need in safe pain management NTRB boosting their profile and credibility with its recent membership to the Russel Indexes The opioid crisis remains one of the most pressing public health challenges of our time. While synthetic opioids like fentanyl play a crucial role in managing severe…

Continue Reading

ThursdayJul 03, 2025 10:30 am

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Builds Funding in Ramp-up to Production on Strategic Mine Tailings Cleanup, and Reuse Project

ESGold is celebrating the successful close of a private placement funding effort that will generate important financing for the company’s planned launch of a mine tailings cleanup and reclamation project later this year The financing drive was oversubscribed by more than 11%, which ESGold executives hail as evidence that investors like the company’s strategy for generating revenue  The company holds 265 mining claims on the historic Montauban mine site in Quebec, covering 13,116 hectares (about 32,410 acres) of gold and silver exploration ESGold expects to begin mill circuit production on the tailings cleanup later this year Mica recovered in the…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000